Sunday, May 18, 2025
5/18/2025
Metabolic miR-137 Effects Contribute to Neuronal Signaling - Modified Project Summary/Abstract Section Here, we focus on the microRNA, miR-137, which is enriched in the brain and strongly linked to Schizophrenia (SCZ) and Bipolar Disorder (BP) with genome-wide significance. In addition to neuropsychiatric symptoms, SCZ and BP patients suffer from ~10-15 year reduction in life expectancy and this early mortality is due to a high prevalence of obesity, Type II Diabetes (T2D), hyperglycemia, elevated cholesterol and triglycerides, high blood pressure, and irregularities in insulin signaling. Our overarching hypothesis is that miR-137 drives both neuronal and metabolic dysfunction, and that metabolic dysfunction contributes to disease susceptibility/progression. Drosophila has served as a powerful genetic model system for studying both neuronal signaling as well as obesity and diabetes because organs, signaling pathways and proteins, as well as neuronal ion channels/receptors are highly conserved across species, and many disease-associated genes are conserved between Drosophila and humans. Using Drosophila as an experimental system, we have found that miR-137 regulates both metabolic and neuronal function. In this application, we propose studies to further our understanding of how miR-137 affects metabolism to ultimately affect neuronal signaling.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).